News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Regulatory (World)
CFDA To Start 60-Day Approvals For INDs Of Oncology Drugs 8/28/2015
WuXi PharmaTech (WX)'s STA Subsidiary Receives First Approval From Japanese Regulatory Authorities 8/27/2015
Arcadia Biosciences (RKDA) Release: Verdeca’s HB4 Stress Tolerance Trait Completes FDA Early Food Safety Evaluation 8/26/2015
Agendia BV Release: NCCN Breast Cancer Guidelines Acknowledge MammaPrint’s Ability to Predict Prognosis 7/28/2015
IndiPharm Awarded Bionexus Status By Malaysian Biotechnology Corporation 7/28/2015
Cellular Biomedicine Group (CBMG) Announces Successful New Certifications For Proprietary Cell And Tissue Preservation Media Kits 7/27/2015
European Medicines Agency Release: Stimulating The Development Of Medicines For Children 7/23/2015
Indian CRO Quality Questioned, As Quest Life Sciences Warned by WHO for HIV Trial Fraud 7/9/2015
BGI Receives Accreditation From The College of American Pathologists 7/6/2015
Innocoll, Inc. (INNL) Announces Qualified Infectious Disease Product (QIDP) Designation For Cogenzia For The Adjunctive Treatment Of Moderate And Severe Diabetic Foot Infection 6/30/2015
Information Update - Health Canada Requests Quarantine Of Drugs Linked To Polydrug Laboratories Due To Data Integrity Concerns 6/25/2015
AOP Orphan Pharmaceuticals AG Strengthens Core CNS Specialty Business With High Promise In Movement Disorder Treatments 6/19/2015
Intellirod Spine Raises Capital And Obtains ISO Certification 6/16/2015
Information Update - Health Canada Requests Quarantine Of Drugs Linked To Zhejiang Hisun Pharma Due To Data Integrity Concerns 6/16/2015
AmpliPhi Biosciences Corporation (APHB)’s Bacteriophage Manufacturing Facility Receives cGMP Certification 6/3/2015
The FDA Accepts To Review Theraclion's Submission For Approval Of An Echopulse Pivotal Trial In The U.S. 6/3/2015
KCR Accomplishes ISO 9001:2008 Certification For All Company Services 5/26/2015
Sinovac Biotech Ltd. (SVA) Receives Site Inspection Notification For EV71 Vaccine Production Facilities 5/14/2015
European Medicines Agency And Evidera Release Draft Opinion On Two Patient-Reported Outcome (PRO) Measures For Evaluating New Treatments For COPD 5/11/2015
T-Bird Pharma Announces Health Canada License Renewal Including Full Authorization To Sell 5/7/2015
Oncolytics Biotech Inc. (ONC.TO) Announces Receipt Of Orphan Drug Designation From The U.S. FDA For Gastric Cancer 5/6/2015
IDEAL CURES Becomes The First Indian Excipients Company To Receive Excipact Certification 5/4/2015
TWi Pharmaceuticals, Inc. USA Announces The Receipt Of State Sales Licenses From All 50 States In The U.S. 4/17/2015
Hospira Slapped Again By the FDA for Plant Problems 4/16/2015
Juniper Pharma Services Obtains Specials Licence 4/16/2015
T-Bird Pharma Inc. Announces Health Canada Submission For Second Production Facility 4/10/2015
Cellular Biomedicine Group (CBMG)'s Shanghai Facility Passes Fourth Consecutive CFDA Inspection 4/6/2015
Innate Pharma (IPH.PA ) : DSMB Recommends Continuation Of Effikir Trial With Two Arms 3/30/2015
European Medicines Agency Release: Gardasil 9 Offers Wider Protection Against Cancers Caused By Human Papillomavirus (HPV) 3/27/2015
Kemwell Announces Successful FDA Inspection 3/24/2015
InMed Receives Exemption Status From Health Canada 3/23/2015
THERAVECTYS Granted Authorization By The French National Agency For Medicines To Produce Lentiviral Vectors For Clinical Use And CAR-T Cell Therapies Under GMP Standards 3/23/2015
Stempeutics Receives Advanced Therapy Medicinal Product (ATMP) Classification From European Medicines Agency For Its Novel Stem Cell Drug 'Stempeucel' 3/23/2015
Mesoblast Limited (MSB.AX) Selected For Fast Track Access To Potential Investment Incentives In Japan 3/19/2015
Tianyin Pharmaceutical Co, Inc. Received Notice Of Non-Compliance With NYSE MKT Continued Listing Requirements 2/27/2015
Medicago, Inc. Awarded A Contract By The U.S. Department Of Health And Human Services To Explore Alternate Production Methods For Ebola Antibodies 2/24/2015
Fake Quote Scandal: Medical Marijuana Firm CEN Biotech Receives Major Setback 2/20/2015
Vexim Announces Successful GMP Inspection by Brazil's National Health Surveillance Agency 2/19/2015
Oncolytics Biotech Inc. (ONC.TO) Announces Receipt Of Orphan Drug Designation From The U.S. FDA For Pancreatic Cancer 2/17/2015
Siegfried Announces Comprehensive Solution For The Hameln Facility’s Regulatory Issues 2/16/2015
T-Bird Pharma Inc. Announces License Renewal From Health Canada 2/10/2015
Oncolytics Biotech Inc. (ONC.TO) Announces Filing For Orphan Drug Designation With The U.S. FDA For High Grade Gliomas In Pediatric Patients 2/9/2015
Horizon Pharma plc.  (HZNP) Announces Issuance Of VIMOVO® Related Patent With Protection To 2031 From United States Patent And Trademark Office 2/5/2015
Tianyin Pharmaceutical Co, Inc.'s JCM Updates On Import Registration For International Clients 1/26/2015
Neuland Labs Reports Another Successful FDA Audit And Wins 2015 CMO Leadership Award 1/26/2015
Tianyin Pharmaceutical Co, Inc. QLF Received GMP Certification 1/20/2015
Veloxis Pharmaceuticals A/S (VELO) Confirms Receipt Of U.S. FDA Administration Decision 1/13/2015
TPI QLF To Receive GMP Certification 1/8/2015
Tauriga Sciences Inc. (TAUG) Confirms That Canadian Trading Halt (Cease Trade) Has Been Lifted By Autorite Des Marches Financiers (Quebec Based Regulatory Authority) 1/8/2015
Buchang Pharma Visits Tianyin Pharmaceutical Co, Inc. Qionglai Facility 1/6/2015
Successful FDA Inspection At Hovione 12/18/2014
EXCLUSIVE: Sanofi Pasteur (SASY.PA) US CMO Says U.S. Regulators Most Interested in Four-Strain Flu Vax 12/18/2014
Anti-Infective Advisory Committee Recommends Approval Of Actavis' Ceftazidime-Avibactam 12/8/2014
Sanofi (SAN.PA) Chairman Says French Tax Burden Is Hindering Hunt For New CEO 12/8/2014
IntelGenx Corp. Grants Extension Of Marketing Exclusivity In The U.S. To Edgemont Pharmaceuticals, LLC. Of Forfivo XL(R) 12/5/2014
Fifteen Indians Blinded After Surgery With Suspected Infected Tools 12/5/2014
China, South Korea OK GlaxoSmithKline (GSK)'s $43B Covidien (COV) Buy 12/5/2014
GVK Biosciences Review: Some Member States Suspend Marketing Authorisations For Concerned Medicines 12/5/2014
ChemoCentryx, Inc. (CCXI) Granted EU Orphan Drug Designation For CCX168, An Orally Administered Complement C5a Receptor Inhibitor, For The Treatment Of Microscopic Polyangiitis And Granulomatosis With Polyangiitis, Two Forms Of ANCA-Associated Vasculitis 12/4/2014
WuXi PharmaTech Co., Ltd. Subsidiary Submits Application To The National Equities Exchange And Quotations In China To List On The New Third Board 12/4/2014
Maharashtra FDA Executes "Surprise Inspection Spree" On Hundreds Of Pharma Units 12/3/2014
Germany Bars Antibiotic Cephalosporin From Ranbaxy Laboratories (RANBAXY.BO)'s Madhya Pradesh Plant 12/3/2014
Rhinomed Mute Granted US FDA Registration 12/3/2014
Novartis AG (NVS)' Heart Failure Medicine LCZ696 Granted Accelerated Assessment By CHMP In Europe 12/2/2014
Relmada Therapeutics Receives Health Canada Clearance To Commence First Clinical Study Of D-Methadone 12/2/2014
Inventiva Receives Another Positive Opinion On Orphan Drug Designation In The European Union For IVA337 – For Idiopathic Pulmonary Fibrosis 12/2/2014
ImmunoCellular Therapeutics, Ltd (IMUC) Receives Positive Regulatory Feedback From European Medicines Agency On Advancing ICT-107 To Phase 3 Program 12/1/2014
FDA Priority Review Voucher Scheme Under Fire 11/26/2014
Beximco Pharmaceuticals Becomes First Bangladeshi Company To Receive GMP Approval From Health Canada 11/24/2014
Yabao Pharmaceuticals In-licenses China Rights To Parkinson's Drug Technology 11/21/2014
Servier Release: European Medicines Agency Recommends Measures To Reduce Risk Of Heart Problems With Corlentor/Procoralan (Ivabradine) 11/21/2014
National Institute for Clinical Excellence (NICE) Requests More Info On Novartis AG (NVS)'s Xolair To Treat Chronic Hives 11/20/2014
Endo Pharmaceuticals (ENDP) Announces Early Termination Of HSR Act Waiting Period In Connection With Its Proposed Acquisition Of Auxilium Pharmaceuticals (AUXL) 11/19/2014
Cell Source's Megadose Drug Combination Receives Regulatory Approval In Italy To Commence Human Clinical Trials 11/13/2014
U.S. FDA Sends Warning Letter To Cadila Pharmaceuticals 11/12/2014
Cardiome Pharma Corp. (COM.TO) Submits BRINAVESS® Reimbursement Dossier To Italian Authorities To Support Market Access 11/10/2014
Actavis (ACT) And Durata Therapeutics, Inc.  (DRTX) Receive U.S. FTC Clearance For Actavis' Proposed Acquisition Of Durata 11/3/2014
Veloxis Pharmaceuticals A/S (VELO) Announces Tentative Approval Of Envarsus® XR 10/31/2014
Tianyin Pharmaceutical Co, Inc.'s QLF Updates On Its GMP Certification Progress 10/23/2014
Clanotech AB Receives Orphan Drug Designation In The EU 10/20/2014
Health Canada Issues Notice Of Compliance For Gilead Sciences, Inc. (GILD)'s Harvoni™ (ledipasvir/sofosbuvir), The First Once-Daily Single Tablet Regimen For The Treatment Of Genotype 1 Chronic Hepatitis C 10/17/2014
China Biologic Products Receives Approval For Commercial Manufacturing Of Human Prothrombin Complex Concentrate At Shandong Taibang Facility 10/17/2014
Health Canada Release: Safety Information On The Risk Of Blood Clots With Immunoglobulin Products 10/13/2014
National Institute for Clinical Excellence (NICE) Rejects Another Roche (RHHBY) Leukemia Drug Citing Data Uncertainties 10/6/2014
Rare Cancers Europe Calls For New Criteria To Be Used In Clinical Trials On Rare Cancer Treatments 10/2/2014
Information Update - Health Canada Takes Action To Stop Import Of Products From Three Sites In India 10/1/2014
U.S. Patent and Trademark Office Issues Can-Fite BioPharma (CFBI) Patent For CF102 In The Treatment Of Liver Regeneration And Function Following Surgery 9/30/2014
Tianyin Pharmaceutical Co, Inc.'s QLF Completes GMP Site Inspection By CFDA 9/29/2014
Information Update - Health Canada Requests Quarantine Of Products For Canadian Market From Apotex Inc. Facility In Bangalore, India 9/25/2014
Medunik Canada Announces Health Canada Priority Review Of PHEBURANE® Indicated For The Treatment Of Urea Cycle Disorders (UCD) 9/24/2014
KemPharm, Inc. Receives Health Canada Approval To Begin KP201 Clinical Trials In Canada 9/23/2014
OxThera, Inc. Release: Oxabact® Granted European Medicines Agency Orphan Drug Designation For Treatment Of SBS 9/23/2014
Natco Pharma Limited, Orchid Chemicals Hit With A Strong Dose Of FDA Medicine 9/19/2014
GlaxoSmithKline (GSK) Resolves Violation Issue At Montana Facility 9/18/2014
Novartis AG (NVS), Roche (RHHBY) Cry Foul On New Swiss Pricing System 9/16/2014
Alchem International Commits To Tropane Alkaloid Apis And Extends Production And Regulatory Support To Resolve Supply Gap 9/15/2014
FDA's Surprise Visit To Sun Pharmaceutical Industries Ltd (SUNPHARMA.NS)'s Pressures Stock 9/12/2014
Tianyin Pharmaceutical Co, Inc. Release: JCM Applies For Azithromycin API Import Certificate At India 9/9/2014
Exco Intouch Achieves Quality Milestone With Iso9001:2008 Certification 8/21/2014
FDA Finds Falsified Data, Serious Mold, And Decaying Frogs At Amanta (Formerly Known As Marck Biosciences) 8/21/2014
WuXi PharmaTech Co., Ltd. Facility Passes FDA Inspection For Manufacture Of API 8/18/2014
Tianyin Pharmaceutical Co, Inc. Release: Qionglai Facility (QLF) Schedules September For GMP Examination 8/18/2014
Protein Sciences Corporation And Liomont Announce Licensing Of Proprietary Influenza Vaccines For The Mexico Market 8/12/2014
Easton Pharmaceuticals (OP: EAPH) Announces Medical Marijuana Site Facility Visit And Inspection 8/12/2014
ZAI Lab Of Shanghai In-Licenses Two Respiratory Drugs From Sanofi 8/12/2014
Cardiome Pharma Corp. (COM.TO) Submits BRINAVESS Dossier To French Authorities To Support Market Access 8/7/2014
Israel's Ministry Of Health Approves Pluristem Therapeutics (PSTI)'s Commercial-Scale 3D Cell Manufacturing Process Used At Its New Haifa Facility 7/31/2014
Successful FDA Inspection At Hovione's API Manufacturing Plant In Cork, Ireland 7/31/2014
FDA Concern Over Drug Production Process At India's Cadila 7/31/2014
FDA Performs Inspection Of IMPAX Laboratories, Inc. (IPXL)'s Taiwan Facility 7/29/2014
India's Ipca Laboratories Halts Shipments To U.S. From Local Plant After FDA Concerns 7/24/2014
Agenus (AGEN) Release: First Vaccine Candidate for Malaria is Accepted for EU Regulatory Review 7/24/2014
Novartis AG (NVS) Plant To Fall Under GlaxoSmithKline (GSK) Control 7/18/2014
Federal Trade Commission Urged To Probe Shire, Sanofi (France) (SAN.PA) & Icahn Med School Over A "Conspiracy" 7/16/2014
Bial And moksha8 Announce Exclusive License For The Commercialization Of Eslicarbazepine Acetate (Zebinix® / Exalief®) In Brazil And Mexico 7/15/2014
Beximco Pharmaceuticals Becomes First Bangladeshi Company To Receive GMP Approval From Taiwan Food and Drug Administration (TFDA) 7/7/2014
Teva Pharmaceutical Industries Limited (TEVA) Tries Out A New Tactic In Battle For Generic MS Drug 7/7/2014
Recordati S.p.A : Carbaglu® Receives Orphan Drug Designation In The U.S. For Organic Acidemias 7/3/2014
FDA Slaps GlaxoSmithKline (GSK) With Warning For Plant Quality Violations, Orders Company To Review Manufacturing Worldwide 6/26/2014
Cellectis (ALCLS)’ UCART19 Receives Advanced-Therapy Medicinal Product Classification From European Medicines Agency 6/23/2014
WuXi PharmaTech Co., Ltd. Tech Toxicology Facility In Suzhou Passes FDA Inspection 6/20/2014
AstraZeneca PLC (AZN) Release: FDA Adcom Recommends No CV Trial For PAMORA Class 6/13/2014
EffRx Receives U.S. Orphan Drug Designation For EX404 For Treatment Of Pediatric Polycystic Ovary Syndrome 6/10/2014
Europeans, U.S. Disagree Over Safety Of Ranbaxy Laboratories (RANBAXY.BO) Facility 6/6/2014
PCI Given The Green Light In Anvisa Audit 6/4/2014
FDA Cites Manufacturing Concerns At Wockhardt (WOCKHARDT.BO)'s U.S. Unit 5/28/2014
Eisai Company, Ltd. (ESALY.PK)'s R&D Subsidiary Kan Research Institute Commences Full-Scale Operation at New Facility 5/26/2014
TxCell Release: Col-Treg Granted Advanced Therapy Medicinal Product (ATMP) Classification By The European Medicines Agency 5/22/2014
FDA Slams Sun Pharmaceutical Industries Ltd (SUNPHARMA.NS) For Continued Violations At Plant 5/22/2014
WuXi PharmaTech Co., Ltd. Toxicology Facility In Suzhou Passes OECD GLP Inspection 5/21/2014
Nordic Nanovector: Betalutin™ Granted Orphan-Drug Designation In The USA 5/20/2014
WuXi PharmaTech Co., Ltd. Facilities For Late- And Commercial-Stage Analytical And Stability Testing And Clinical-Trial Materials Manufacturing Pass FDA Audit 4/30/2014
Flamel Technologies (FLML) Announces Receipt Of Complete Response Letter From FDA Citing Issues At The Facility Of The Supplier Of The Active Ingredient 4/29/2014
Pluristem Therapeutics (PSTI)'s Manufacturing Facility Approved By European Auditors For Phase 3 Trials 4/28/2014
Lonza Inc.'s Facility In Singapore Received Good Manufacturing Practice (GMP) Certification From The HSA 4/17/2014
FDA Moving Slow To Add Drug Inspectors In China 4/8/2014
ChemCon GmbH Successfully Passes Its Fourth FDA Inspection 4/3/2014
AXIS Clinicals Announces Successful Completion Of 13th U.S. FDA Audit 3/27/2014
Aesica Successfully Completes The Validation Of Its High Capacity Manufacturing Facility At Queenborough, UK Site 3/14/2014
POLARIS Announces Illumina CSPro Certification For Sequencing 3/14/2014
Northwest Biotherapeutics (NWBO) Receives Authorization For New Cancer Therapy In Accordance With $4 Billion German Medical Act 3/12/2014
FDA Approves Pluristem Therapeutics (PSTI)'s Commercial Scale Cell Manufacturing Process 3/6/2014
Basilea Pharmaceutica (BSLN.SW) Reports That Isavuconazole Receives Qualified Infectious Disease Product Designation From FDA For The Treatment Of Invasive Mucormycosis 2/27/2014
ChinaBio(R) LLC Release: China Implements 30-Day Review For "Simple" M&A Transactions 2/26/2014
Neurosearch A/S (NEUR.CO) Announces The Danish Business Authority's Decision In The Accounting Control Matter 2/21/2014
Pluristem Therapeutics (PSTI) Submits FDA Orphan Drug Application For Preeclampsia 2/20/2014
Selvita Received A GMP Certificate 2/18/2014
GMP Certification Boost For Cobra Biologics Ltd. 2/11/2014
Aratana Therapeutics (PETX) Announces Conditional Approval Of Second Canine-Specific Antibody Therapy 1/28/2014
Ranbaxy Laboratories (RANBAXY.BO) Workers Fudged Test Results: FDA 1/28/2014
Protalix Biotherapeutics, Inc. (PLX) Announces Successful Manufacturing Facility Evaluation By Health Canada 1/24/2014
Pluristem Therapeutics (PSTI)'s Cell Manufacturing Facility Marks Major Milestone With German Regulatory Approval Of New Scaled-Up 3D Manufacturing Process 1/23/2014
Suven Life Sciences Ltd's Pashamylaram's Unit Receives FDA Acceptance 1/22/2014
Fraunhofer IZI Granted Manufacturing Authorization For Second GMP Facility 1/21/2014
Exco InTouch Successfully Completes HIPAA Security Audit 1/20/2014
Bayer HealthCare (BAY) Commends AHS And CAPC For Updated Heartworm Guidelines 1/20/2014
ChinaBio(R) LLC Release: China Adds Regs To New IPO Process 1/17/2014
Vectura Group plc (VEC.L): Swedish Regulatory Authority Confirm Approval Of Airflusal® Forspiro® 1/14/2014
BASF Received Excipact™ Certification As Pharmaceutical Excipient Supplier 1/8/2014
TaiGen Biotechnology Receives Qualified Infectious Disease Product And Fast Track Designations From The FDA For Nemonoxacin (Taigexyn®) 12/23/2013
Daiichi Sankyo, Inc. (4568.t) To Help Ranbaxy Laboratories (RANBAXY.BO) Meet FDA Norms 12/19/2013
R-Biopharm Rhône Ltd Welcomes Scottish Government Moves To Improve Food Safety Standards 12/12/2013
China Agrees To Allow Ten Additional FDA Inspectors 12/9/2013
Reckitt Benckiser Pharmaceuticals Inc. Pharma Unit In The U.S. Is Raided By The Feds 12/9/2013
Wockhardt (WOCKHARDT.BO) Falls 4%, FDA Says Company Erased Key Trial Data 12/4/2013
FDA Approval For SCM Pharma Limited Following BTG plc (BTG.L)'s Drug Approval 12/3/2013
TxCell Obtains Manufacturing Accreditation Status For Its French Cell Therapy Manufacturing Facility 12/3/2013
ChemCon GmbH Receives Approval To Manufacture Semi-Solid Pharmaceuticals For Human Use 12/3/2013
Eisai Company, Ltd. (ESALY.PK) Submits Application For Proton Pump Inhibitor Pariet In Japan 11/28/2013
Biogen Idec, Inc. (Massachusetts) (BIIB) Release: CHMP Determines Dimethyl Fumarate In TECFIDERA® To Be A New Active Substance In The European Union 11/22/2013
Gentium S.p.A. Receives European Medicines Agency Orphan Drug Designation For Defibrotide For The Prevention Of GvHD 11/19/2013
Amgen (AMGN) and Sanofi (France) (SAN.PA) Drugs Can Reach U.S. Without Long Studies 11/15/2013
Drug Regulator Asks Sun Pharmaceutical Industries Ltd to Halt Clinical Research at Mumbai Laboratory 11/11/2013
Specialised Therapeutics Australia Receives Therapeutic Goods Administration Approval for Brain Tumour Visualisation Drug - Gliolan® 11/11/2013
Eisai Company, Ltd. (ESALY.PK) Submits Application To Expand Indication Of Anti-Alzheimer's Agent Aricept® As Treatment For Dementia With Lewy Bodies In Japan 10/31/2013
Mesoblast Limited (MSB.AX) Updates Market on Registration Plans for GVHD Cell Product in Japan 10/28/2013
UK Regulator to Withdraw Approval for Wockhardt (WPL)'s Daman Plant 10/22/2013
Novasep's European Custom Manufacturing Passes FDA Inspection 10/22/2013
Cambridge Major Laboratories, Inc. Announces Successful FDA Inspection At Weert Facility 10/21/2013
WuXi PharmaTech Co., Ltd. Receives CLIA Certification for Its Genomics Clinical Laboratory 10/17/2013
Wockhardt (WPL) Falls After U.K. Regulator Action on Factory 10/14/2013
Ranbaxy Laboratories (RANBAXY.BO) Jumps as US Plant Wins FDA Clearance 10/11/2013
Fujifilm Diosynth Biotechnologies' UK Site Receives Renewed Medicines and Healthcare Products Regulatory Agency Manufacturing Licence 10/9/2013
FDA Accuses USV of Fudging Data 9/23/2013
ImmunoGen, Inc. (IMGN) Announces Positive Regulatory Decisions for Roche (RHHBY)'s Kadcyla® in the European Union and Japan 9/20/2013
Failure by Drugmakers, Researchers to Publish Clinical Trial Results Risk Patient Safety: UK Lawmakers 9/17/2013
Medivir AB (MVIRb.F): The Regulatory Process in Japan for Simeprevir 9/17/2013
BioIndustry Association Flagship UK Bioscience Forum is Now CPD-Certified 9/12/2013
NicOx SA (COX.PA) Receives Positive Opinion for European Orphan Drug Designation for Naproxcinod for the Treatment of Duchenne Muscular Dystrophy 9/11/2013
Procognia Limited Announces Receipt of cGMP Certificate for Its Glycosylation Analysis Services 9/3/2013
Lonza Inc. Issues Guidance on Infection Control Regarding Novel Coronaviruses (nCoV), Including the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) 8/29/2013
GH Genhelix Receives GMP Approval 8/6/2013
FDA Approves BioGaia's Request for Orphan Drug Designation 8/6/2013
After Novartis AG (NVS) Scandal, Japan Considers Penalties for False Data 8/6/2013
Urine, Lies and a Wayward Drugmaker: FDA Tells Off Wockhardt 7/24/2013
Oncodesign SA Awarded Accreditation of Its Research Center by International Association, AAALAC 7/18/2013
Wockhardt Barred From Making Drugs for Europe 7/10/2013
Datamonitor Release: AMNOG May Cause Havoc in German Diabetes Market - Analyst Opinion 7/9/2013
Genethon, the French AFM-Telethon Laboratory, Becomes the First Not-for-Profit to Obtain Authorization From ANSM to be a Pharmaceutical Manufacturer 7/8/2013
India Upholds Cancellation of Johnson & Johnson (JNJ) Plant License 6/25/2013



//-->